Skip to content
Screener

SI-BONE, Inc. SIBN Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$10M0.0%
Bioventus logo
BioventusBVS
$10M0.0%
3D Systems logo
3D SystemsDDD

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$844.38M+27.1%
Enterprise value$853.79M+28.0%
P/S4.1×+0.5×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001459839-26-000056
Line itemMarch 31, 2026December 31, 2025
TOTAL LIABILITIES63,77661,023
Commitments and contingencies (Note 6)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 44,201,473 and 43,647,131 shares issued and outstanding, respectively44
Additional paid-in capital633,029626,970
Accumulated other comprehensive income501816
Accumulated deficit(454,592)(450,258)

Item 1. Financial Statements

FAQ

What is SI-BONE, Inc.'s preferred stock, shares authorized?
SI-BONE, Inc. (SIBN) reported preferred stock, shares authorized of $5M in Q1 2026.
How has SI-BONE, Inc.'s preferred stock, shares authorized changed year-over-year?
SI-BONE, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for SI-BONE, Inc.'s preferred stock, shares authorized?
Over 5 years (2020 to 2025), SI-BONE, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.

Ask your AI about SI-BONE, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude